Goldman Sachs Group Inc Atara Biotherapeutics, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.44 - $1.22 $148,690 - $412,277	-337,932 Reduced 58.05%	244,257 $168,000
Q4 2023 Feb 13, 2024	SELL	$0.23 - $1.74 $814,710 - $6.16 Million	-3,542,220 Reduced 85.88%	582,189 $296,000
Q3 2023 May 14, 2024	BUY	$1.41 - $2.31 $4.99 Million - $8.18 Million	3,542,220 Added 608.43%	4,124,409 $6.1 Million
Q3 2023 Nov 14, 2023	SELL	$1.41 - $2.31 $617,008 - $1.01 Million	-437,595 Reduced 9.59%	4,124,409 $6.1 Million
Q2 2023 May 14, 2024	SELL	$1.5 - $3.04 $3.16 Million - $6.41 Million	-2,109,699 Reduced 31.62%	4,562,004 $7.34 Million
Q2 2023 Aug 14, 2023	SELL	$1.5 - $3.04 $3.16 Million - $6.41 Million	-2,109,699 Reduced 31.62%	4,562,004 $7.34 Million
Q1 2023 May 14, 2024	BUY	$2.8 - $5.46 $1.2 Million - $2.34 Million	428,090 Added 6.86%	6,671,703 $19.3 Million
Q1 2023 May 11, 2023	BUY	$2.8 - $5.46 $1.2 Million - $2.34 Million	428,090 Added 6.86%	6,671,703 $19.3 Million
Q4 2022 May 14, 2024	BUY	$2.85 - $5.18 $4.23 Million - $7.69 Million	1,484,933 Added 31.2%	6,243,613 $20.5 Million
Q4 2022 Feb 13, 2023	BUY	$2.85 - $5.18 $4.23 Million - $7.69 Million	1,484,933 Added 31.2%	6,243,613 $20.5 Million
Q3 2022 May 14, 2024	BUY	$2.85 - $8.73 $5.19 Million - $15.9 Million	1,820,384 Added 61.95%	4,758,680 $18 Million
Q3 2022 Nov 10, 2022	BUY	$2.85 - $8.73 $5.19 Million - $15.9 Million	1,820,384 Added 61.95%	4,758,680 $18 Million
Q2 2022 May 14, 2024	BUY	$4.69 - $9.84 $11.1 Million - $23.2 Million	2,356,107 Added 404.7%	2,938,296 $22.9 Million
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $3.28 Million - $6.89 Million	-699,810 Reduced 19.24%	2,938,296 $22.9 Million
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $9.06 Million - $18.1 Million	1,073,579 Added 41.86%	3,638,106 $33.8 Million
Q4 2021 Feb 14, 2022	SELL	$14.7 - $19.89 $4.55 Million - $6.16 Million	-309,750 Reduced 10.78%	2,564,527 $40.4 Million
Q3 2021 Nov 10, 2021	BUY	$11.99 - $17.9 $34.5 Million - $51.4 Million	2,874,277 New	2,874,277 $51.5 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account